Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. - Wikidata - awgldk - TriplyDB

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

http://www.wikidata.org/entity/Q45303215

about

Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease Diabetic kidney disease: a report from an ADA Consensus Conference Updates on the management of diabetes in dialysis patients Developing an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients.Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with moderate to severe renal impairment: a systematic review and meta-analysis Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: A1C remains the gold standard outcome predictor in diabetic dialysis patients. Counterpoint.Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS).Comprehensive approach to diabetic nephropathy.Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients.Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis Evidence-based cardiology in hemodialysis patients Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients.Changes in antidiabetic prescription patterns and indicators of diabetic control among 200,000 patients over 13 years at a single institution in Japan.Implications for glucose measures in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?Hemoglobin a1c in the ESRD population: status report.Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors.Measurement of Hba(1C) in patients with chronic renal failure.High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis.The Effect of Glycated Hemoglobin and Albumin-Corrected Glycated Serum Protein on Mortality in Diabetic Patients Receiving Continuous Peritoneal Dialysis.A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease.Glycosylation Gap in Patients with Diabetes with Chronic Kidney Disease and Healthy Participants: A Comparative Study.Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis.Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes.The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients.Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis.Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.Glycated albumin is a more accurate glycemic indicator than hemoglobin A1c in diabetic patients with pre-dialysis chronic kidney disease.Anti-inflammatory effects of linagliptin in hemodialysis patients with diabetes.Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin.Monitoring Glycemic Control in End-Stage Renal Disease: What Should Be Measured?Glycated albumin. A glycemic control index to be reevaluated

P2860

Q26827458-5BDCF213-0C1D-4099-8FF9-EB08BC91CF3D Q27012546-E42EE405-195A-4B93-ABFA-69C0C4657D73 Q27024782-3622B05D-995F-4F8D-BE4E-BB0EE1964932 Q30413995-AE5B3307-9868-4AC9-9387-095603591591 Q34425731-EF42490C-5BA5-44CA-AB82-7E6BE3AE9975 Q35382193-6D782CB2-84C4-4629-8598-326EDC4CE054 Q35682211-F8CF3D5E-8CC9-41D2-A24A-799BFFC7CC6F Q36047184-07F8F384-E9B8-4BCF-A44C-CDBA6B7BADBD Q36159157-B4E32951-A8B7-43E9-8C8F-D9CABE2FF2BC Q36426859-C483129F-2753-48C3-82A3-748CB182BCCE Q36466019-14C59015-6D7F-4290-90AB-8F2046657C32 Q36868213-178A230E-EEEC-44F0-ACAE-7D000A945B1D Q37176045-32F18D4B-C2E3-4E38-BF2A-190E5BD10412 Q37340239-6570BD03-6759-4F2C-BB2F-854BBA67AFF5 Q37352182-86200199-D2B6-40F7-8398-2EDEEA49CDC4 Q37406062-C1BDB8D8-0A8C-409D-B302-91A5282CB717 Q37670162-770D8FFC-6BCF-4CAE-968F-660020DA1DA3 Q38013676-FFABA1F6-7D91-4F34-8F54-9491B3496EB5 Q38182542-EA659095-DC80-4029-A46D-B871EC794090 Q38231450-A2D67825-7FC1-4F6D-AF25-9CDA14A4EB35 Q38541323-2B30E88B-57C3-4A32-ACA5-062F4A800942 Q38541529-9A8E5C56-A4DD-4D44-B527-5E9F3BCD54B6 Q40543073-7ECE9454-2D0B-48B4-AB85-732EC85EEC78 Q41109810-C4F7653D-C5F0-4A84-94CC-EC2B392501F8 Q41808839-7311E616-CC6C-499A-BBCC-BAFD5298B81C Q42261290-EC7CD942-FC5A-4144-A9D1-5F81FFCBE18D Q42286738-005223AF-ACAF-406F-A9E2-894E286D9441 Q46231385-744ED052-2F82-4BF8-B21D-776F84552B6D Q46428227-8116EC85-20BD-4FC2-8BB0-CA8266E5CEAB Q46740944-0B46C82A-E4E2-41EB-88BA-5415643B9288 Q47257414-1EA4C9B4-76B2-42F6-BD84-B305164F9F7E Q48041579-884814B1-C1A5-404E-A13B-3606197E3D66 Q49593330-2AB2AFC5-3671-4839-BBB1-73750433F4CA Q50179675-0E5A2366-CEA1-4B79-80BF-59ACD68A806A Q51302961-1234D291-EB23-40C5-9032-CE90C486A15D Q51759934-1CA772AB-07B8-495A-9DFC-779D6521E5DF Q54572186-523272C3-DCBF-4AE7-A4E4-B6C0D354AF0B Q55002223-AAC78FF4-C775-4449-81CB-B40A58DAC62A Q55046674-D3EF2628-446B-4185-9460-550592ABDE7B Q58055764-25D11729-7F9B-491A-B87D-E3AC7A8F308E

P2860

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

http://www.wikidata.org/entity/Q45303215

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@en

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@nl

type

label

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@en

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@nl

prefLabel

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@en

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@nl

P1433

Q45303215-A3067C00-AC08-431B-A214-9B31CE99C2C9

P1476

Q45303215-E710D9DC-270E-4B27-8FA4-85C403A43B8C

P2093

Q45303215-02CE7D77-EEF9-452B-9895-5AF8BCB92E55

Q45303215-185EBC7E-A1AA-4129-95AF-4B3A2608BE87

Q45303215-24D0C875-3A75-49CB-97D1-93E0FE73FFD0

Q45303215-407B4FC4-0BAD-4BFC-BDE8-0C5C277A852C

Q45303215-425FA04F-FD23-4C87-B753-C03871A729BB

Q45303215-50A222F7-9BD7-458B-BA70-7AAF8669F8BE

Q45303215-58F9EB0F-2F00-44A3-A831-DD29C1F62B08

Q45303215-5B468FE9-1CDA-4E00-8835-1F76ECD2115B

Q45303215-5FB79243-3BAC-4635-97AC-0BAD3ED6025B

Q45303215-62A7BBE3-4142-4AEF-AD82-9FA1347C7F76

P304

Q45303215-4B52B3F6-F9EE-4770-A649-F7BB69D31451

P31

Q45303215-461A881E-B226-46D5-BE01-20AAEF187968

P356

Q45303215-AEECB7AB-2943-4A33-B72F-A6CD13C9C052

P433

Q45303215-D7B9BDD9-6D8E-4CEA-B182-626D7B5926F0

P478

Q45303215-40037340-3D39-4628-85E6-36B61C045CC0

P577

Q45303215-F31A67C7-B278-4530-8C9B-05C8EF2CE3BB

P698

Q45303215-6D153D93-015A-45FD-AECE-9308C0B1C898

P921

Q45303215-04D553CE-1E95-4092-8CA0-7AA0ABEBCC36

Q45303215-0A16E29F-B730-4272-BBE3-874575CEC6EB

Q45303215-B00172F6-773E-4107-8EC1-42674C1FA85A

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.

@en

P2093

Angie D Graham

http://www.w3.org/2001/XMLSchema#string

Anthony J Bleyer

http://www.w3.org/2001/XMLSchema#string

Barry I Freedman

http://www.w3.org/2001/XMLSchema#string

Cesar Y Cardona

http://www.w3.org/2001/XMLSchema#string

David L Henderson

http://www.w3.org/2001/XMLSchema#string

Gregory B Russell

http://www.w3.org/2001/XMLSchema#string

Jean R Jordan

http://www.w3.org/2001/XMLSchema#string

Joyce R Byers

http://www.w3.org/2001/XMLSchema#string

Leah M Courchene

http://www.w3.org/2001/XMLSchema#string

Lilian Andries

http://www.w3.org/2001/XMLSchema#string

P304

1635-1643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.11491210

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21597024

http://www.w3.org/2001/XMLSchema#string

P921

hospitalization